SHS_543117 REPP CGZM 16112

A Prospective 24-Month Observational Study to Evaluate Neurocognitive Function and Safety in Patients with Relapsing Multiple Sclerosis Who Are Initiating LEMTRADA Treatment in Routine Clinical Practice

A Prospective 24-Month Observational Study to Evaluate Neurocognitive Function and Safety in Patients with Relapsing Multiple Sclerosis Who Are Initiating LEMTRADA Treatment in Routine Clinical Practice
N/A
Neurosciences, All Other
Multiple Sclerosis
Pavle Repovic, M.D.
Genzyme
Aaleen Cox
  • Swedish Medical Center